BeOne Medicines Ltd. — Insider Transactions
Form 4 filings by directors, officers, and 10%+ shareholders
SEC rules require corporate insiders — including directors, executive officers, and any shareholder owning more than 10% of a company's shares — to report changes in their ownership within two business days of a transaction. These disclosures are filed as Form 4. Open-market purchases (code P) are generally considered the most meaningful signal, as insiders are spending their own money.
| Insider | Title | Type | Shares | Price | Value | Owns After | Date |
|---|---|---|---|---|---|---|---|
| OYLER JOHN | Chief Executive Officer | Sale | 5,829 | $304.37 | $1,774,173 | 84,095 | Dec 16, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 332 | $325.00 | $107,900 | — | Dec 10, 2025 |
| Sanders Corazon (Corsee) D. | — | Sale | 1,823 | $340.20 | $620,185 | 804 | Nov 26, 2025 |
| Wu Xiaobin | President and COO | Sale | 3,155 | $380.23 | $1,199,626 | 836 | Nov 17, 2025 |
| Wu Xiaobin | President and COO | Sale | 4,240 | $380.33 | $1,612,599 | 1,769 | Nov 12, 2025 |
| Lee Chan Henry | SVP, General Counsel | Option Exercise | 296 | $159.03 | $47,073 | 996 | Nov 12, 2025 |
| OYLER JOHN | Chief Executive Officer | Gift | 151,320 | — | — | 7,299,574 | Nov 12, 2025 |
| Wang Xiaodong | — | Gift | 424,073 | — | — | 4,582,601 | Nov 7, 2025 |
| Lee Chan Henry | SVP, General Counsel | Option Exercise | 296 | $159.03 | $47,073 | 9,559 | Oct 8, 2025 |
| OYLER JOHN | Chief Executive Officer | Sale | 12,446 | $326.14 | $4,059,138 | 4,408 | Sep 16, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 300 | $326.80 | $98,040 | 500 | Sep 10, 2025 |
| Wang Xiaodong | — | Gift | 148,096 | — | — | 5,006,674 | Sep 9, 2025 |
| Wang Lai | Global Head of R&D | Sale | 5,000 | $350.06 | $1,750,300 | — | Sep 9, 2025 |
| Sanders Corazon (Corsee) D. | — | Option Exercise | 2,665 | $155.68 | $414,887 | 2,665 | Sep 5, 2025 |
| Ball Titus B. | Principal Accounting Officer | Sale | 122 | $326.76 | $39,865 | — | Sep 2, 2025 |
| Wu Xiaobin | President and COO | Sale | 5,800 | $302.04 | $1,751,832 | 33,736 | Aug 13, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 3,849 | $301.00 | $1,158,549 | — | Aug 13, 2025 |
| Rosenberg Aaron | Chief Financial Officer | Sale | 1,190 | $290.47 | $345,659 | — | Aug 1, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 920 | $304.60 | $280,232 | — | Jul 30, 2025 |
| Wang Lai | Global Head of R&D | Sale | 800 | $304.16 | $243,328 | 259 | Jul 29, 2025 |
| Wang Lai | Global Head of R&D | Sale | 700 | $300.00 | $210,000 | — | Jul 18, 2025 |
| OYLER JOHN | Chief Executive Officer | Sale | 1,553 | $254.83 | $395,751 | — | Jul 9, 2025 |
| Wang Xiaodong | — | Sale | 1,100 | $265.35 | $291,885 | 607 | Jun 24, 2025 |
| Wang Lai | Global Head of R&D | Sale | 1,028 | $260.00 | $267,280 | — | Jun 23, 2025 |
| Wu Xiaobin | President and COO | Sale | 1,363 | $260.00 | $354,380 | — | Jun 23, 2025 |
| OYLER JOHN | Chief Executive Officer | Sale | 100 | $262.90 | $26,290 | — | Jun 23, 2025 |
| OYLER JOHN | Chief Executive Officer | Sale | 3,680 | $266.05 | $979,064 | 1,460 | Jun 17, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 422 | $266.50 | $112,463 | — | Jun 16, 2025 |
| Wang Lai | Global Head of R&D | Sale | 470 | $251.37 | $118,144 | — | Jun 16, 2025 |
| Wu Xiaobin | President and COO | Sale | 1,443 | $265.47 | $383,073 | 730 | Jun 16, 2025 |
| Ball Titus B. | Principal Accounting Officer | Award / Grant | 29,601 | — | — | 73,983 | Jun 11, 2025 |
| Lee Chan Henry | SVP, General Counsel | Award / Grant | 46,878 | — | — | 283,920 | Jun 10, 2025 |
| Rosenberg Aaron | Chief Financial Officer | Award / Grant | 63,674 | — | — | 230,802 | Jun 10, 2025 |
| Wang Lai | Global Head of R&D | Award / Grant | 86,359 | — | — | 1,058,304 | Jun 10, 2025 |
| Wu Xiaobin | President and COO | Award / Grant | 123,370 | — | — | 1,274,296 | Jun 10, 2025 |
| Wang Xiaodong | — | Award / Grant | 98,696 | — | — | 5,180,861 | Jun 10, 2025 |
| OYLER JOHN | Chief Executive Officer | Award / Grant | 185,055 | — | — | 8,281,841 | Jun 10, 2025 |
| Yi Qingqing | — | Other | 29,614 | — | — | 27,326 | Jun 10, 2025 |
| Lee Chan Henry | SVP, General Counsel | Sale | 230 | $256.79 | $59,062 | — | Jun 6, 2025 |
| Wang Lai | Global Head of R&D | Sale | 202 | $251.89 | $50,882 | 600 | Jun 6, 2025 |
| Wu Xiaobin | President and COO | Sale | 400 | $250.74 | $100,296 | 1,534 | Jun 6, 2025 |
| OYLER JOHN | Chief Executive Officer | Sale | 927 | $254.97 | $236,357 | 400 | Jun 6, 2025 |
| Yi Qingqing | — | Award / Grant | 10,985 | — | — | 56,940 | May 21, 2025 |
| Sharp Shalini | — | Award / Grant | 10,985 | — | — | 19,136 | May 21, 2025 |
| BRANDICOURT OLIVIER | — | Award / Grant | 10,985 | — | — | 27,326 | May 21, 2025 |
| Riva Alessandro | — | Award / Grant | 10,985 | — | — | 56,940 | May 21, 2025 |
| Dugan Margaret | — | Award / Grant | 10,985 | — | — | 56,940 | May 21, 2025 |
| Sanders Corazon (Corsee) D. | — | Award / Grant | 10,985 | — | — | 57,226 | May 21, 2025 |
| HOOPER ANTHONY C | — | Award / Grant | 10,985 | — | — | 64,740 | May 21, 2025 |
| Baker Brothers Life Sciences LP | — | Award / Grant | 21,970 | — | — | 148,065 | May 21, 2025 |